Upstate New York Association of Physicists in Medicine, Inc.      (A Chapter of the AAPM)
Fall Meeting -
Tuesday October 18th, 2011

Zebro Conference Center

Roswell Park Cancer Institute

Elm and Carlton Streets

Buffalo, NY 14263

 

Sponsoring Vendor Exhibits:

LACO Inc & PTW, ACCURAY Inc., Upstate Linac Services, VARIAN, ELEKTA, TomoTherapy, Velocity Medical Solutions, SUN Nuclear, VisionRT, BARD, ScandiDos

                                   

MEETING SPONSOR

VARIAN

 

10:30

Business Meeting

11:45

Lunch                                                    Sponsored by  Upstate Linac Services and ELEKTA

12:50

Meeting Introduction

Iris Wang Ph.D., UNYAPM President

Vendor Session

1:00

4D Quality Assurance

PTW Regional Product Manager 

1:15

The Cyberknife Radiosurgery System – Technology Update

Vance Sorell, Accuray Inc.

Proffered Paper Session

1:45

Investigating the Usability of BIM (Brain Imaging Material) as a Water Equivalent Material in Neurovascular Imaging Studies

Brendan Loughran

TSRC, University at Buffalo

2:00

Increasing x-ray tube output while maintaining the small effective focal spot for the Microangiographic Fluoroscope (MAF) System

Sandesh Gupta

TSRC, University at Buffalo

2:15

The Optimization of Stereotactic Body Radiation Therapy (SBRT) from a Simple Field Order Rearrangement

Jonathan Schmitt

Roswell Park Cancer Institute

2:30

Dose Reduction technique for Image Guided Neurovascular Intervention

Setlur Nagesh, Swetadri Vasan

Dept of E.E., TSRC, University at Buffalo

2:45

Competency and Credentialing: Current AAPM Initiatives

Daniel C. Pavord

Vassar Brothers Hospital

3:00

Refreshments and Vendor Exhibits                          Sponsored by Upstate Linac Services and ELEKTA

Invited Talk

3:20

Lifetime Achievement Award presentation

 

3:30-4:30

Cancer Imaging for Radiotherapy

Thomas Rockwell Mackie, Ph.D. FAAPM

University of Wisconsin

 

ADJOURN


UNYAPM 2011 FALL MEETING PROCEEDINGS

 

 

ABSTRACTS

 

 

1)      Investigating the Usability of BIM (Brain Imaging Material) as a Water Equivalent Material in Neurovascular Imaging Studies

Brendan Loughran, Ciprian N Ionita, Daniel R Bednarek, Stephen Rudin

Toshiba Stroke Research Center, University at Buffalo

Purpose: We investigated a homemade putty or BIM as a tissue equivalent attenuator in neurovascular stent imaging studies.  Previously, the standard AAPM lateral head phantom was used to conduct preliminary technique parameter estimations prior to clinical research and it was found that the technique parameters were severely underestimated.  This is likely because most neurovascular stenting procedures require imaging at the portion of the brain which is at the bony base of the skull.  Therefore, to improve preliminary technique parameter estimations, the use of an anatomical head phantom and BIM is beneficial.  The BIM should be somewhat water equivalent and must easily conform to the irregular interior regions of the skull.

Methods: The BIM was made from salt, water, and flour.  X-rays at technique parameters of 74 kVp and 0.02 mAs were then passed through the BIM.  The exposure was recorded by a PTW chamber and electrometer at the entrance of the material, after 1 inch, and after 2 inches.  The same was done with water equivalent plastic and the exposures were compared.    

Results: The entrance exposure for both the BIM and water equivalent plastics was 38.1 µR/frame.  The exposures at 1 inch and 2 inches of BIM were 14.0 µR/frame and 5.83 µR/frame, respectively.  The exposures at 1 inch and 2 inches of water equivalent plastic were 17.5 µR/frame and 9.25 µR/frame, respectively.  The percent difference between the BIM and the water equivalent plastic was 20.0% at 1 inch and 37.0% at 2 inches.

Conclusion: We find that the BIM conforms better to the complex and irregular portions of the interior of the anatomical head phantom than the water equivalent plastic.  The differences in attenuation between the BIM and the water equivalent plastic have been quantified.  For our purposes, the BIM adequately mimics the physical and attenuation characteristics of brain tissue.  Therefore, we can conclude that the BIM is a useful tissue approximating material.

 

2)      Increasing x-ray tube output while maintaining the small effective focal spot for the Microangiographic Fluoroscope (MAF) System

S Gupta, A Jain, DR Bednarek, S Rudin

Toshiba Stroke Research Center, University at Buffalo

Purpose: High-resolution region-of-interest (ROI) imaging requires the use of a small effective focal-spot with sufficient output to maintain spatial and contrast resolution for endovascular-image-guided interventions (EIGIs). We investigate two possible methods to increase the x-ray output while maintaining the effective focal-spot size for the Microangiographic Fluoroscope (MAF) System.

Materials and Methods: In the first method, we evaluated the increase in tube output for the MAF made possible by reducing the anode angle and lengthening the filament for the small focal -spot to maintain a constant effective focal-spot size while assuming flux density and heat distribution as unchanged. “Spek Calc” software was used to calculate the change in inherent tube filtration and in x-ray spectrum and intensity  as a function of anode angle. In the second method, generalized MTF (GMTF), generalized NNPS (GNNPS) and generalized NEQ (GNEQ) were calculated for the MAF at a fixed object magnification of 1.11 for the medium and small focal-spots on the central axis and the medium focal spot on the anode side.  

Results: The x-ray output could be increased by 3.3 times with a 2-degree anode angle compared to the standard 8-degree target with an increase of 4 times in filament length, following the first method. The GNEQ of medium focal spot with at the anode side is higher at all frequencies below the Nyquist due to the reduced effective focal spot size, following the second method.

Conclusions: For EIGIs where high resolution is essential but only over a small FOV, higher tube output while maintaining a small focal-spot should be achievable with only small modification of standard x-ray tube geometry. Furthermore, there is a clear benefit to utilizing the increased tube output for the medium focal-spot, while decreasing the effective anode angle to reduce focal-spot size for the MAF.

Support: NIH Grants R01-EB008425, R01-EB002873

 

3)      The Optimization of Stereotactic Body Radiation Therapy (SBRT) from a Simple Field Order Rearrangement

Jonathan Schmitt, Graham Warren, Iris Wang

Roswell Park Cancer Institute

Purpose: Stereotactic Body Radiation Therapy (SBRT) uses high dose fractions with multiple co-planar and non-coplanar beams. Due to the large fractional doses, SBRT treatments are typically protracted and the number of fields is greater than a conventional radiation treatment. We demonstrate a temporal optimization method could be applied to SBRT treatments to enhance biological effectiveness.

Methods: Clinically treated SBRT cases were studied. Using the Lea-Catcheside protraction factor (G-value), we cycled through possible field-order permutations for each treatment plan, and determined an optimal and a least-favorable field order. For comparison, clinically delivered field orders were also included. We utilized the Lethal Potential Lethal (LPL) model to quantify the difference in survival fraction. To acquire the parameters needed by the LPL model we fit the data to three non-small cell lung cancers (NSCLC): H460, H660, and H157. The results are expressed as the ratios  and , where N is the number fractions in the SBRT protocol.

Results: Our results verified that maximization of cell kill is achieved by orienting the fields in a D pattern, where the fields with greatest dose are positioned in the center. Minimization of cell kill occurred when fields with smallest dose were positioned centrally and higher dose fields were placed in the beginning and end of the fraction. This orientation resembled a V shape. The survival fraction ratios calculated using the LPL model showed that regardless of the cell type the D shape had lower cell survival fractions compared to both the clinical example (C) and the V arrangement. For example, results of H460 cell line, with T1/2 = 0.25 h, showed the D pattern is approximately 10 times more effective than a clinical field order, after 5 fractions.

Conclusion: Using theoretical models we have shown that rearrangement of the field orders for a SBRT treatment could optimize cell kill and potentially affect overall treatment outcome.

 

4)      Dose Reduction technique for Image Guided Neurovascular Intervention

S.N Swetadri Vasan1,2, A. Panse2 ,A. Jain2,  P. Sharma1,2, Ciprian N. Inonita2, A.H. Titus1,2,

 A.N. Cartwright1,2,  D.R Bednarek2, S. Rudin1,2

    1Department of Electrical Engineering, University at Buffalo, 2 Toshiba Stroke Research Center, University at Buffalo

X-ray endovascular image-guided interventions are carried out using the insertion and navigation of catheters through the vasculature under fluoroscopic image guidance. Once the catheter is guided closer to the site of the pathology to be treated, the need for detailed image information outside this region is reduced and the dose to the patient can be reduced. In this paper we present a novel approach to achieve patient dose reduction, by reducing the dose outside the treatment area. A material x-ray region of interest (ROI) attenuator is used to reduce the dose incident to the patient. The region of the image under the attenuator has fewer x-ray quanta reaching the detector, hence noisier, as compared to the non attenuating region with less noise. This results in an image with differential brightness.

First the image is equalized in brightness by post processing and then a spatially different temporal filter with higher weight is applied to the high attenuating region to reduce the noise at the cost of some loss in temporal resolution, however a lower temporal weight is used inside the region of interest to preserve temporal resolution. A simulation of this technique on an image sequence obtained from a Neurovascular intervention is presented.

 

5)      Competency and Credentialing: Current AAPM Initiatives

Daniel C. Pavord

Vassar Brothers Hospital

Ensuring the competency of staff in radiation oncology is critical to providing safe and effective patient care.  To help achieve this, there are three initiatives in process within AAPM to provide guidance and resources to clinical staff in this area.

First, a subcommittee of the Clinical Practice Committee on Competency and Credentialing has been formed.  This group has produced a guidance report that is in the approval process in Professional Council.  The scope of the report is:

  1. A framework to develop medical physics competencies in a variety of situations: a. Solo physicist vs. larger group, b. Experienced physicist vs. new graduate, c. Initial competency evaluation (credentialing) vs. ongoing competency evaluation, d. Implementation of new procedures or technology.
  2. A set of criteria for physicians and administrators to evaluate the content of a competency program.

Specific areas to be addressed are: Policies and procedures, New staff evaluation, Existing staff evaluation, Outside reviews, Training, and Staffing.

Secondly, a task group on simulation training has been formed.  This group will produce a white paper on the use of simulation training in radiation oncology.  Many areas such as the airline industry have shown this type of training to be highly effective in improving safety.

Lastly, a proposal has been submitted to develop an online system for the documentation of competency for specific procedures.  From the proposal: Derek Brown, Peter Dunscombe and colleagues have created a pilot system called the RTP Learning Centre [Med. Phys. 38, 3829 (2011)]. This system comprises four specific levels for attaining and maintaining competency in special procedures. The proposed pathway would involve the general steps toward competency in a specific area being determined from Practice Guidelines from AAPM, ASTRO, ACR, etc. by CPC subcommittee on Competency and Credentialing. One of the methods to attain competency would be through the use of simulation training as described by TG194. The proposed system would be the framework that would standardize competency and credentialing in Medical Physics with extension to other members of the Radiation Oncology team.

 

Vendor’s session

 

1)      4D Quality Assurance - The PTW OCTAVIUS 4D allows for true independent verification of IMRT Planning.

By: PTW Regional Product Manager

 

2)      The Cyberknife Radiosurgery System – Technology Update

By: Vance Sorell, Accuray Inc.

A presentation on the basic components of the Cyberknife Radiosurgery system with a focus on the unique use of the 3D space around the patient.  The robotic mechanism provides an advantage for radiation therapy treatments by targeting volumes and minimizing or eliminating the placement of beams through the organs at risk.  This generates treatment plans with radiosurgery margins and high dose conformality with rapid dose fall-off.  The robotic movement uniquely allows for real time tumor tracking by correcting beam placement through imaging and motion correlation.

 

 


Keynote Speaker – 2011 UNYAPM Lifetime Achievement Award Honoree

 

Thomas Rockwell Mackie, Ph.D., Dr. Thomas “Rock” Mackie has a bachelor degree in Physics from the University of Saskatchewan (1980) and a doctorate in Physics from the University of Alberta (1984).  His expertise is in radiation physics, radiation therapy treatment planning, radioisotopes and radiation delivery for cancer.  Dr. Mackie is a professor in the departments of Medical Physics, Human Oncology, and Engineering Physics at the University of Wisconsin-Madison and the Director of Medical Devices at the Morgridge Institute for Research. He has authored or co-authored more than 150 publications, mentored more than 25 Ph.D. students and has more than 30 inventions with issued patents. He co-founded a radiation therapy treatment planning company called Geometrics which developed the PinnacleTM treatment planning system now marketed by Philips Medical.  He was a co-founder and Chairman of the Board of TomoTherapy, Inc. now owned by Accuray. He is on the Board of Novelos Therapeutics, a developer of radiopharmaceutics and is also on the board of Shine Medical Technologies, a radioisotope production company, and BioIonix, a water purification company based on electro-catalytic processes.

 

Cancer Imaging for Radiotherapy

Thomas Rockwell Mackie, Ph.D., FAAPM, Professor

University of Wisconsin

Other than the first Co-60 cancer therapy unit, the most important advance in the management of cancer with radiotherapy has come about because of improvements in imaging. More than 25 years ago conventional planar x-rays were the main tool used to image a radiation therapy patient.  Conventional x-rays can accurately reveal the location of bone and lung in two dimensions, but most cancer involves soft tissue not bone and the exact shape and extent of lung cancer in three dimensions is poorly determined. X-rays were only useful for localizing the general anatomical site of the disease not the exact site to be treated.  This meant that very large treatment margins were used, thereby limiting the dose to the tumor to avoid normal tissue complications.  The advent of the computed tomographic (CT) scanner revealed soft tissue structures with millimeter precision in three-dimensions that could theretofore only be visualized during surgery.   At the same time the availability of relatively inexpensive computers enabled the CT images to be used to visualize where beams of radiation could be applied to the tumor in ways which would avoid as much as possible harm to normal sensitive tissue.  This treatment planning process also included a more accurate calculation of the radiation dose to be delivered to the patient using methods that were largely developed by Canadian medical physicists.  These developments allowed higher doses of radiation to be more safely delivered. Today, all radiotherapy clinics have CT scanners specialized for planning treatments.  Scanning before each treatment ensures the tumor is being adequately covered and the normal tissue not receiving too much radiation.  The use of conventional x-rays has been nearly completely replaced by CT scanners for use in radiotherapy, however, planar x-rays still have a very important role in specialized diagnostic exams for cancer. 

Medical imaging for cancer is evolving rapidly.  Magnetic resonance imaging (MRI) reveals some soft tissue structures with more specificity and at higher resolution than a CT scanner can.  A positron emission tomographic (PET) scanner is able to reveal not only anatomy but the uptake of tracers that can signal the location of rapidly growing or metabolizing cells - the hallmark of cancer.  In the United States virtually all lung cancer patients receive at least one PET scan.  PET tracers under development will reveal whether a particular patient’s tumor is more resistant to treatment than usual.  MRI and PET images superimposed on CT scans often possess information greater than the sum of the imaging sets alone.  It will become more and more common to image patients earlier in the diagnostic workup process especially if they are at increased risk of having cancer.  MRI and PET scanners are the most expensive imaging systems to buy and operate. 

With increased use of modern imaging systems, cancer will be made a chronic disease for those that fail the first round of treatment.  Patients should be followed up often after treatment using appropriate imaging resources.  If there is residual disease even at distance anatomic sites, additional treatments are appropriate, so long as the risk of complications can remain low.  The earlier the recurrence is detected and therefore the smaller it is, the more likely a single convenient and cost-effective dose of radiation can be safely administered.  Finding the recurrence early often means the disease can be eliminated at that site. Careful accounting of, and minimizing, the dose to healthy tissue will keep the quality of life high.  Imaging will also reveal if the disease is so extensive that intervention could not be safely administered. It is highly likely that the number of years patients survive with a high quality of life, will steadily increase over the next 25 years as imaging for cancer becomes less expensive and even more capable.

 

 

 


 

Directions (to Roswell Park Cancer Institute):

 

From points east, west, north and south of Buffalo: Take the New York State Thruway (Interstate 90) to Exit 51W (Route 33 West, also called the Kensington Expressway). Exit from Route 33W at Locust St. Turn right at the first traffic light (Michigan Avenue). Continue on Michigan Avenue for two blocks to Carlton Street. Turn left at the traffic signal. Our intersection is Elm and Carlton Streets, Buffalo, NY 14263.

 

 

When arriving at Roswell Park, you may park your car in the parking ramp on Carlton Street. The Zebro Conference Center is located in the Buffalo Life Science Complex. Enter the BLSC building from Virginia Street. The Zebro room is on the ground floor. Vendors’ exhibits will be in the foyer area.